Download FREE Sample
Report Overview
Women-s health diagnostics refers to medical tests and screening procedures designed to detect, monitor, and manage health conditions specific to women. These diagnostics cover a broad range of diseases, including breast and cervical cancer, osteoporosis, reproductive and fertility issues, and sexually transmitted infections among others. They utilize advanced technologies such as molecular diagnostics, imaging, next-generation sequencing, and point-of-care testing to enable early detection and personalized treatment and others. With increasing awareness, government initiatives, and technological advancements, women-s health diagnostics play a crucial role in preventive healthcare, improving outcomes, and reducing disease burden through timely and accurate medical intervention.
"aligncenter wp-image-9509 size-full" title="Women-s Health Diagnostic" src="https://meditechinsights.com/wp-content/uploads/2025/06/Womens-Health-Diagnostics-Market.png" alt="Women-s Health Diagnostic" width="922" height="518" />To learn more about this report, download the PDF brochure
Increasing prevalence of women-s health disorders to propel market demand
The increasing prevalence of women-s health disorders, such as breast cancer, cervical cancer, osteoporosis, and polycystic ovary syndrome, is a major driver of the women-s health diagnostics market. Rising disease prevalence necessitates early detection and continuous monitoring, fueling demand for advanced diagnostic solutions. According to WHO, in 2022, there were 2.3 million women diagnosed with breast cancer and 670,000 deaths globally, highlighting the need for improved screening technologies. Additionally, growing awareness and government initiatives promoting routine screenings are encouraging higher adoption of diagnostic tests. This trend is driving innovation in molecular diagnostics, imaging, and point-of-care testing, enhancing early disease detection and treatment outcomes.
Advancements is are driving the market growth
Advancements in diagnostic technologies are driving the women-s health diagnostics market by improving accuracy, efficiency, and accessibility of disease detection. Innovations such as next-generation sequencing, liquid biopsy, AI-powered imaging, and molecular diagnostics enable early and precise identification of conditions like breast and cervical cancer, osteoporosis, and fertility disorders. Additionally, point-of-care and at-home diagnostic solutions provide faster, more convenient testing. These advancements reduce diagnostic errors, enable personalized treatment, and support preventive healthcare, increasing the adoption of cutting-edge diagnostic tools in women-s health.
To learn more about this report, download the PDF brochure
Competitive Landscape Analysis
The global women-s health diagnostics market is marked by the presence of established and emerging market players such as F. Hoffmann-La Roche Ltd, Hologic, Inc., "https://www.questdiagnostics.com/">Quest Diagnostics Incorporated, Abbott, BD, GE Healthcare, Koninklijke Philips N.V., PerkinElmer, Thermo Fisher Scientific Inc., and BIOMRIEUX; among others. Some of the key strategies adopted by market players include new product development, strategic partnerships and collaborations, and geographic expansion.
Report Scope
| Report Metric | Details |
| Base Year Considered | 2024 |
| Historical Data | 2023 - 2024 |
| Forecast Period | 2025 - 2030 |
| Growth Rate | 7% |
| Market Drivers |
|
|
|
| Segment Scope | Application, End User |
| Regional Scope |
|
| Key Companies Mapped | F. Hoffmann-La Roche Ltd, Hologic, Inc., Quest Diagnostics Incorporated, Abbott, BD, GE Healthcare, Koninklijke Philips N.V., PerkinElmer, Thermo Fisher Scientific Inc., and BIOMRIEUX among others |
| Report Highlights | Market Size & Forecast, Growth Drivers & Restraints, Trends, Competitive Analysis |
Global Women-s Health Diagnostics Market Segmentation
This report by Medi-Tech Insights provides thesize of the global women-s health diagnostics market at theregional- and country-level from 2023 to 2030. The report further segments the market based on, application, end user.
Market Size & Forecast (2023-2030), By Application, USD Million
- Osteoporosis Testing
- OVC Testing
- Cervical Cancer Testing
- Breast Cancer Testing
- Pregnancy & Fertility Testing
- Infectious Disease Testing
- STD Testing
- Others
Market Size & Forecast (2023-2030), By End User, USD Million
- Hospitals & Clinics
- Diagnostic and Imaging Centers
- Home Care Settings
- Others
Market Size & Forecastllion
- North America
- US
- Canada
- Europe
- UK
- Germany
- France
- Italy
- Spain
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Rest of Asia Pacific
- Latin America
- Middle East & Africa
Key Strategic Questions Addressed
- What is the market size & forecast of the women-s health diagnostics market?
- What are historical, present, and forecasted market shares and growth rates of various segments and sub-segments of the women-s health diagnostics market?
- What are the key trends defining the market?
- What are the major factors impacting the market?
- What are the opportunities prevailing in the market?
- Which region has the highest share in the global market? Which region is expected to witness the highest growth rate in the next 5 years?
- Wholayers operating in the market?
- What are the key strategies adopted by players?
Need a More Tailored Analysis?
- Discuss the market sizing methodology and forecast assumptions with our healthcare analysts.
- Expand the scope with additional countries, market segments, technologies, or competitor profiling.
- Use the insights to support strategic planning, market entry, commercial due diligence, and long-term revenue growth initiatives.
